MAPT and Alzheimer disease: Therefore, it is quite probable that a meta-analysis of the Aβ42/p-tau ratio in MCI cases converting to AD in ≤24 months would provide a satisfactory negative likelihood ratio, given that both p-tau and the Aβ42/T-tau ratio showed optimal results.